Pittsburgh, PA, May 30, 2023—Margaret Rosenzweig, PhD, FNP-BC, AOCNP®, FAAN, will begin her appointment as the Oncology Nursing Society’s (ONS’s) scholar-in-residence (SIR) June 1, 2023.
As SIR, Rosenzweig will work with Erica Fischer-Cartlidge, DNP, CNS, AOCNS®, EBP-C, ONS chief clinical officer, to create a strategic vision for ONS’s research resources and processes to support people with cancer and the growing need for nurse researchers in cancer care. Rosenzweig will also collaborate with organizations and nurse scientists to address emerging oncology research priorities at the national level.
“We are very excited to have Dr. Rosenzweig as our SIR to engage with and elevate the voice of the oncology nurse scientist community,” Fischer-Cartlidge said. “Her wealth of experience and research portfolio align strongly with the ONS Enterprise mission, and our collaboration will drive oncology nursing research forward.”
Rosenzweig’s research explores the deep phenotyping of patients as an individual in their own social and physical context as they embark on cancer care. Her early research findings led to the Symptom Experience, Management, and Outcomes According to Race and Social Determinants of Health (SEMOARS) during chemotherapy for early-stage breast cancer, a study funded by the National Institute on Minority Health and Health Disparities. SEMOARS is a multisite study comparing the incidence, distress, reporting methods, and outcomes, including the ability to receive full doses of prescribed chemotherapy, between Black and White patients as they proceed through early-stage breast cancer treatment. Her current research funding also includes a Genentech Corporation Community Grant Program to study those social determinants of health, along with biologic correlates, in other cancers.
“As ONS’s next SIR, I believe we must recognize that oncology nursing overall, and specifically oncology nursing research, is a powerful force for quality cancer care,” Rosenzweig said. “I bring the roles of nurse scientist, clinician, educator, and patient and community advocate to the SIR role, and I look forward to identifying the ONS research community’s strengths and needs. We must honor the long tradition of oncology nursing research at ONS while energetically moving forward in understanding and caring for the patient, family, and community.”
A Distinguished Service Professor of Nursing at the University of Pittsburgh School of Nursing in Pennsylvania, Rosenzweig has published more than 130 peer-reviewed articles and is one of the first nurse practitioners nationally to specialize in oncology. She taught oncology nurse practitioners for many years and developed a nationally available, online oncology nurse practitioner orientation course, funded through the National Cancer Institute. Her clinical practice as a nurse practitioner focuses on metastatic breast cancer.
Rosenzweig is a leader for the Oncology Nursing Foundation Research Intensive, serving in both 2021 and 2023. In addition, she is the co-chair of the Pennsylvania Comprehensive Cancer Control Program’s Disparity Committee and serves on the Western Pennsylvania American Cancer Society board of directors to advocate for greater cancer control legislation.
ONS is a professional association that represents 100,000 nurses and is the professional home to more than 35,000 members. ONS is committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families. Learn more at ons.org.